HR 7828
117th Congress
House
Health
PRICED Act
Introduced: May 18, 2022
Introduced by:
Schakowsky, Janice D.
Democratic
· Illinois
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 18, 2022
Referred to the House Committee on Energy and Commerce.
May 18, 2022
Introduced in House
Plain-English summary
Price Relief, Innovation, and Competition for Essential Drugs Act or the PRICED Act
This bill allows biosimilars to be marketed five years after the reference brand-name biological product is licensed. Currently, brand-name biological products are provided a 12-year marketing-exclusivity period.
This shortened marketing-exclusivity period applies only to biological products licensed by the Food and Drug Administration after enactment of this bill.
What's happening now
Referred to the House Committee on Energy and Commerce.
Committees of jurisdiction
1